Laboratorios Richmond SACIF
BCBA:RICH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Laboratorios Richmond SACIF
BCBA:RICH
|
AR |
|
C
|
Capital Engineering Network PCL
SET:CEN
|
TH |
|
abrdn Property Income Trust Ltd
LSE:API
|
GG |
Intrinsic Value
The intrinsic value of Laboratorios Richmond SACIF (RICH) under the Base Case is 1 993.63 ARS per share. Compared with the current market price of 1 420 ARS, the stock appears Undervalued by 29% .
The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 18% a year over the next five years, less than a third of its five-year pace of 68%. Operating margin ends at 19% by 2036, above its five-year average of 17%.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Laboratorios Richmond SACIF Does
Laboratorios Richmond is an Argentine pharmaceutical company that develops, manufactures, and sells prescription medicines. Its main business is making finished drugs for human use, with a strong focus on complex treatments such as medicines for chronic diseases and specialized therapies. It sells mainly to pharmacies, hospitals, public health buyers, and distributors that supply doctors and patients.
- Headquarters
- Argentina AR
- IPO date
- Dec 22, 2017
Revenue & Expenses Breakdown
Laboratorios Richmond SACIF
Earnings Waterfall
Laboratorios Richmond SACIF
The intrinsic value for Laboratorios Richmond SACIF (RICH) under the Base Case is 1 993.63 ARS.
Compared with the current market price of 1 420 ARS, the stock appears Undervalued by 29% .